ABEC, a global provider of engineering solutions and services for biotech manufacturing, is investing $11 million to expand its disposable container manufacturing capability in single-use for its custom single run (CSR) biomanufacturing solutions. The company's site in Wilson, NC, includes a 4,600 square meter facility on 13 acres, which will feature an ISO-7 certified clean room and state-of-the-art manufacturing equipment. The new site will be ABEC's third global disposable container manufacturing site and is expected to be fully operational in early Q2 2023.
BETHLEHEM, Pa.--(BUSINESS WIRE)--ABEC, a leading global provider of engineered solutions and services for biotech manufacturing, today announced it will provide customized, large-scale bioprocess equipment, including a 14,500 liter total volume stainless steel fermenter and an 8,000 liter media preparation system to EKF Life Sciences, a division of EKF Diagnostics Holdings plc, which manufactures diagnostics enzymes and contracted custom products for use in medical diagnostics, pharmaceutical and industry. The agreement provides EKF Life Sciences’ South Bend, Indiana facility with the bioprocess equipment which will significantly expand EKF’s production capacity of enzymes used in a variety of diagnostic and Life Science applications.
BETHLEHEM, Pa.--(BUSINESS WIRE)--ABEC, a global provider of engineered solutions and services for biotech manufacturing, today announced the completion of an expansion of its Fermoy, Ireland cleanroom for single-use disposable container (DC) manufacturing. The expansion increases total floorspace in Fermoy to 9,500 square feet and includes state-of-the-art automated manufacturing equipment. The expansion is fully operational and comes at a pivotal time for the biopharmaceutical industry as many customers cite lead times of a year or more from other suppliers.
BETHLEHEM, Pa. & CHARLOTTETOWN, Prince Edward Island--(BUSINESS WIRE)-- ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing and BIOVECTRA, a CDMO specializing in clinical-to-commercial scale production of high-quality regulated Biologics, Active Pharmaceutical Ingredients, and intermediates, today announced ABEC will design, manufacture, and install CSR single-use microbial fermentation solutions at BIOVECTRA’s manufacturing facility in Windsor, Nova Scotia, Canada. ABEC’s fast-track manufacturing schedule will enable BIOVECTRA to be fully operational by Q2, 2022.